手法を比較

	WHOQOL-BREF	EQ-5D	SF-12健康調査
分野	健康測定	健康測定	健康測定
系統	Process / pipeline	Process / pipeline	Process / pipeline
提唱年	1998	1990	1996
提唱者	World Health Organization Quality of Life Group	EuroQol Group	John E. Ware Jr., Mark Kosinski, and Susan Keller
種類	Multidimensional quality of life assessment	Generic preference-based health utility measure	Brief self-report health status instrument
原典	The WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558.	Rabin, R., & de Charro, F. (2001). EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.	Ware, J. E., Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.
別名	WHOQOL-BREF Questionnaire, WHO Quality of Life-BREF	EQ-5D-3L, EQ-5D-5L, EuroQol	SF-12v2, Medical Outcomes Study SF-12
関連	5	5	4
概要	The WHOQOL-BREF is the brief version of the World Health Organization's quality of life assessment, developed by the WHO Quality of Life Group and published in 1998. It measures quality of life across physical, psychological, social, and environmental domains in a single 26-item self-report questionnaire. It has become the primary quality of life instrument in global health research and clinical practice.	The EQ-5D is a standardized, preference-based health utility measure developed by the EuroQol Group in 1990. It combines a descriptive health profile (five dimensions, three or five response levels) with a visual analog scale to quantify overall health status. The instrument has become essential for health economics, clinical trials, and cost-effectiveness analysis worldwide.	The SF-12 is a brief, 12-item version of the SF-36 health survey developed by Ware, Kosinski, and Keller in 1996. Designed to reduce respondent burden while maintaining psychometric validity, it has become the standard instrument for large-scale surveys, epidemiological studies, and health outcomes research where administration time is critical.